A Genetically Engineered Plasmodium falciparum Parasite Vaccine Provides Protection from Controlled Human Malaria Infection

The authors assessed the safety, tolerability, and immunogenicity of the PfGAP3KO vaccine and tested its efficacy against controlled human malaria infection in malaria-naïve subjects.